Utilization and prescription patterns of phosphidiesterase-5 inhibitor medications in the United States military health system-Reference-Cited by-同舟云学术

Utilization and prescription patterns of phosphidiesterase-5 inhibitor medications in the United States military health system

Published:2018-06-11 Issue:6 Volume:30 Page:300-305
ISSN:0955-9930
Container-title:International Journal of Impotence Research
language:en
Short-container-title:Int J Impot Res

Author:

Montgomery Jon,Madsen Cathaleen,Leroux Todd,Koehlmoos Tracey Pérez

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://www.nature.com/articles/s41443-018-0037-3.pdf

Reference20 articles.

1. Armed Forces Health Surveillance Center (AFHSC). Erectile dysfunction among male active component service members, U.S. Armed Forces, 2004-2013. MSMR. 2014;21:13–6.

2. Kubin M, Wagner G, Fugl-Meyer AR. Epidemiology of erectile dysfunction. Int J Impot Res. 2003;15:63–71.

3. Selvin E, Burnett AL, Platz EA. Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007;120:151–7.

4. Lowe G, Costabile RA. 10‐year analysis of adverse event reports to the Food and Drug Administration for phosphodiesterase type‐5 inhibitors. J Sex Med. 2012;9:265–70.

5. Nurnberg HG, Duttagupta S. Economic analysis of sildenafil citrate (Viagra) add-on to treat erectile dysfunction associated with selective serotonin reuptake inhibitor use. Am J Ther. 2004;11:9–12.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Oral Doses of Youkenafil Hydrochloride, a Phosphodiesterase Type 5 Inhibitor, in Healthy Chinese Male Volunteers;Clinical Pharmacology in Drug Development;2022-05

2. Is It All in My Head? Self-reported Psychogenic Erectile Dysfunction and Depression Are Common Among Young Men Seeking Advice on Social Media;Urology;2020-08

3. An update on the drug safety of treating erectile dysfunction;Expert Opinion on Drug Safety;2019-08-30

4. Editorial Comment on “Utilization and Prescription Patterns of Phosphidiesterase-5 Inhibitor Medications in the United States Military Health System”;International Journal of Impotence Research;2018-08-10